rediff.com

News APP

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  gplay

Sign in  |  Create a Rediffmail account

Dcgi Singh

Subscribe via RSS
Rediff.com  »  News  »   Dcgi Singh

  News for Dcgi Singh

  • News
  • Business

Covovax as Covid booster jab to be available on CoWIN soon

 In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute's Covovax on the CoWIN......

DCGI approves market authorisation for Covovax as Covid booster dose

 The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or......

Expert panel bats for Covovax as Covid booster jab for adults

 An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's COVID vaccine Covovax as a heterologous booster dose for adults who have......

Poonawala's Serum Inst to soon launch India's first cervical cancer vaccine

 India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in an......

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

 The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......

Quality Lapses Shut Down Drug Makers

 Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories. IMAGE: Kindly note the image has been posted only......

How India narrowly escaped a health crisis

 The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases. The delay by the health ministry in approving the sale of......

Why is Novartis likely to lose Tiamulin drug licence?

 Swiss drug maker Novartis is likely to face legal action for allegedly faking documents to seek registration of its veterinary product Tiamulin Hydrogen Fumarate (80 per cent granules) in India.......

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

 The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain.  Ranbaxy whistle-blower Dinesh Thakur,......

Keep us in loop before any FDA swoop, India tells US

 Inspections only in domestic authorities’ presence, visiting US drug regulator told Taking a tough stand on the ongoing regulatory issues faced by the domestic pharmaceutical industry because......

Top Coverage News

World Test Championship 2023

 India held the top position in the ICC Men's Test Team Rankings while Australia secured the...

Manipur's Tragedy

 Here are news, updates and coverage from violence hit Manipur.

IPL 2023

 Complete coverage of IPL 2023

Sri Lanka's Tour of India 2023

 Complete Coverage of Indian cricket team's encounter with Sri Lanka during 3rd Jan - 15th Jan 2023.

GUJARAT, HIMACHAL GO TO POLLS

 The Bharatiya Janata Party was on Thursday poised for a landslide victory in Gujarat to retain...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
rediff on the net© 2024 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Feedback - About us | Terms of use - Grievances